Background: Daunorubicine, a type of anthracycline, is a drug commonly used in cancer
chemotherapy that increases survival rate but consequently compromises with …

Background Cardiotoxicity is one of the most common adverse events of the chemotherapy.
Physical exercise was shown to be cardioprotective. We aim to estimate the efficacy and …

Severe cardiotoxic effects limit the efficacy of doxorubicin (DOX) as a chemotherapeutic
agent. Activation of intracellular stress signaling networks, including p38 mitogen-activated …

Anthracyclines such as doxorubicin (Dox) are the preferred chemotherapeutics for several
cancers. However, Dox-induced cardiotoxicity limits its therapeutic potential. Liposomal …

Triple-negative breast cancer is more aggressive than other types of breast cancer. Protein
kinase R (PKR), which is activated by dsRNA, is known to play a role in doxorubicin …

Global longitudinal strain (GLS) is a sensitive predictor of cardiotoxicity in adults with cancer.
However, the significance of abnormal GLS during childhood cancer treatment is less well …

Abstract Aims Anthracyclines (ANTs) are essential chemotherapeutic agents; however, their
adverse effects can lead to heart failure in cancer survivors. While long non-coding RNAs …

Anthracycline toxicity describes the toxic consequences of anthracycline-class medications.
Anthracyclines, such as doxorubicin and epirubicin, are potent chemotherapy agents …

Anthracyclines, chemotherapeutic agents used to treat common forms of cancer, increase
cardiovascular (CV) complications, thereby necessitating research regarding interventions …

Background Bone marrow transplantation (BMT) has significantly improved survival rates in
various hematological malignancies. However, this has led to an increased prevalence of …